ArticleJournal of nanobiotechnology2026
Long-term exposure to polystyrene microplastics exacerbates seizure symptoms via lipid metabolic disruption and ferroptosis: insights from multi-omics analyses.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
As a consequence of global industrial growth, microplastics (plastic fragments < 5 mm) have become ubiquitous environmental contaminants, prompting serious questions about their impact on human health. Beyond the established risks of ingestion, the inhalation of these airborne particles is now a primary focus, especially regarding potential effects on the neurological system. Emerging evidence from laboratory and animal models shows that inhaled microplastics can penetrate the brain. Once there, they can trigger a cascade of harmful effects, including neuroinflammation, oxidative stress, and deficits in learning and memory. Among the general population, children are uniquely vulnerable to microplastic exposure due to their developing physiological systems, which are particularly susceptible to the chemical and physical hazards posed by these particles. Nevertheless, current scientific understanding of the health consequences of microplastic exposure remains limited, with a substantial knowledge gap concerning the long-term effects of respiratory microplastic exposure on pediatric populations, particularly those with pre-existing neurological conditions such as epilepsy. This study investigates the relationship between chronic respiratory exposure to polystyrene microplastics and seizure severity, with the aim of establishing a potential exposure-metabolite-gene regulatory network. We hypothesize that prolonged respiratory mciroplatsic exposure induces systemic oxidative stress and inflammation, which subsequently disrupts lipid metabolism, alters gene expression profiles, triggers ferroptosis, and ultimately exacerbates seizure manifestations.This study highlights three key findings. First, chronic respiratory microplastic exposure induces systemic oxidative stress and inflammation, posing substantial health risks. Second, integrated metabolomics and Mendelian randomization analyses reveal that this exposure disrupts lipid metabolism, with metabolic perturbations strongly associated with ferroptosis activation and increased seizure severity. Third, multi-omics approaches coupled with in vivo validation confirm that microplastics disrupt lipid homeostasis, dysregulate ferroptosis-related gene expression, and exacerbate seizure manifestations. Notably, our data identify melatonin as a promising therapeutic candidate for mitigating these adverse effects. Collectively, these findings substantially advance the understanding of microplastic-induced neurotoxicity and reveal actionable molecular targets for potential therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.